외래 주입 센터 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Ambulatory Infusion Center Market size is expected to reach USD 59.66 Billion in 2034 from USD 26.82 Billion (2025) growing at a CAGR of 9.29% during 2026-2034.

The ambulatory infusion center market is evolving rapidly as outpatient care models and targeted therapies expand. Future centers will integrate AI-driven patient scheduling, real-time infusion monitoring, and digital therapeutic adherence platforms to enhance operational efficiency and patient safety. IoT-enabled infusion pumps and wearable biosensors will support remote monitoring and proactive intervention.

Emerging centers will leverage automation in pharmacy compounding, robotic medication dispensing, and data-driven resource allocation to optimize treatment delivery. Predictive analytics will enable capacity planning, personalized therapy protocols, and real-time performance tracking. Integration with electronic health records and telehealth systems will facilitate seamless care coordination across multiple sites.

Future growth will be fueled by chronic disease prevalence, biologic therapy adoption, and cost-effective outpatient care models. By combining digital health infrastructure, automated operations, and patient-centric delivery, ambulatory infusion centers will redefine outpatient therapeutics, improving accessibility, safety, and clinical outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type of Centers

• Hospital-based Infusion Centers
• Physician-based Infusion Centers
• Independent Infusion Centers

By Therapy Type

• Antibiotics
• Blood Products
• Nutritional Products
• Immunosuppressants
• Immunostimulants
• Monoclonal Antibodies
• Immunoglobulin Therapy
• Others

By Disease Specialties

• Oncology
• Pulmonology
• Neurology
• Gastrointestinal
• Immunology
• Cardiology
• Others (Dermatology, Orthopedic, Rheumatology, etc.)

COMPANIES PROFILED

• FlexCare Infusion Centers, Hawaii Medical Service Association, Pure Infusion Suites, National Infusion Center Association, TwelveStone Health Partners, Richmond University Medical Center, CitusHealth, Valley Health System, CedarsSinai, Arnot Health, PharmaScript
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AMBULATORY INFUSION CENTER MARKET: BY TYPE OF CENTERS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type Of Centers
• 4.2. Hospital-based Infusion Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Physician-based Infusion Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Independent Infusion Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AMBULATORY INFUSION CENTER MARKET: BY THERAPY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy Type
• 5.2. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Nutritional Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Immunosuppressants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Immunostimulants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Immunoglobulin Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AMBULATORY INFUSION CENTER MARKET: BY DISEASE SPECIALTIES 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Disease Specialties
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pulmonology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Gastrointestinal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others (Dermatology, Orthopedic, Rheumatology, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AMBULATORY INFUSION CENTER MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type Of Centers
  • 7.2.2 By Therapy Type
  • 7.2.3 By Disease Specialties
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type Of Centers
  • 7.3.2 By Therapy Type
  • 7.3.3 By Disease Specialties
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type Of Centers
  • 7.4.2 By Therapy Type
  • 7.4.3 By Disease Specialties
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type Of Centers
  • 7.5.2 By Therapy Type
  • 7.5.3 By Disease Specialties
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type Of Centers
  • 7.6.2 By Therapy Type
  • 7.6.3 By Disease Specialties
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AMBULATORY INFUSION CENTER INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 FlexCare Infusion Centers
  • 9.2.2 Hawaii Medical Service Association
  • 9.2.3 Pure Infusion Suites
  • 9.2.4 National Infusion Center Association
  • 9.2.5 TwelveStone Health Partners
  • 9.2.6 Richmond University Medical Center
  • 9.2.7 CitusHealth
  • 9.2.8 Valley Health System
  • 9.2.9 Cedars-Sinai
  • 9.2.10 Arnot Health
  • 9.2.11 PharmaScript